Kidney injury during VEGF inhibitor therapy

Antiangiogenic therapy targeting vascular endothelial growth factor (VEGF) or its receptor (VEGFR) has proven its effect in the treatment of several types of cancer, including renal cell carcinoma (RCC). However, treatment can be accompanied by notable adverse effects. Mild proteinuria and hypertens...

Full description

Saved in:

Bibliographic Details
Published in:	Netherlands journal of medicine Vol. 70; no. 6; pp. 267 - 271
Main Authors:	DEN DEURWAARDER, E. S. G, DESAR, I. M. E, STEENBERGEN, E. J, MULDERS, P. F, WETZELS, J. F. M, HERPEN, C. M. L. Van
Format:	Journal Article
Language:	English
Published:	Alphen aan den Rijn Van zuiden 01-08-2012
Subjects:	Biological and medical sciences General aspects Glomerulosclerosis, Focal Segmental Humans Kidney Medical sciences Nephrotic Syndrome Proteinuria Vascular Endothelial Growth Factor A Kidney toxicity Trauma Kidney Medicine Vascular endothelium growth factor Treatment anti-VEGF therapy Urinary system FSGS Inhibitor Anti-VEGF Lesion Antiangiogenic agent Nephrotoxicity Cediranib
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!